Fatty Liver Disease (NAFLD)
Management of non-alcoholic fatty liver disease.
Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Clinical Guidelines
CKS: Non-alcoholic fatty liver disease (NAFLD)
National
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver diseaseNational
NICE guideline [NG49]National
NICE guideline [NG49]: Non-alcoholic fatty liver disease (NAFLD): assessment and managementNational
2022 Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease (NAFLD)Local
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureLocal
AASLD Practice Guidance: Clinical Assessment and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Local
AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Reduce NAFLD and NASH ProgressionLocal
AGA Clinical Practice Update on the Role of Noninvasive Tests in the Evaluation and Management of Patients With Nonalcoholic Fatty Liver DiseaseLocal
American Association of Clinical Endocrinology Clinical Practice Guideline: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical SettingsLocal
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver diseaseLocal
EASL–EASD–EASO Clinical Practice Guidelines on the management of non-alcoholic fatty liver diseaseLocal
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Local
NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in ChildrenLocal
NICE guideline [NG49]: Non-alcoholic fatty liver disease (NAFLD): assessment and managementLocal